http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108290882-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
filingDate 2016-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108290882-B
titleOfInvention Crystalline forms of a 4-quinazolinamine derivative for the treatment of respiratory syncytial virus infection
abstract The present invention relates to the compound (I) (3-amino-oxetan-3-ylmethyl) - [2- (5, 5-dioxo-5, 6,7, 9-tetrahydro-5. lambda.6. thia-8-aza-benzocyclohepten-8-yl) -6-methyl-quinazolin-4-yl]-novel crystalline forms of amines, and pharmaceutical compositions containing the crystalline forms thereof disclosed herein, which are useful for the treatment or prevention of viral diseases or diseases caused by Respiratory Syncytial Virus (RSV) infection in patients associated with RSV infection. The invention also relates to compositions and uses of the title compounds of the invention in amorphous form.
priorityDate 2015-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013020993-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103717589-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015110446-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413005975
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71262247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424636277
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84759

Total number of triples: 23.